Prostatic Cancer Versus Androgen Deficiency (AndroCan)

Hopital Foch

Status: Completed

Conditions: Cancer of Prostate

Treatments: Other: Blood sample

Study type: Interventional

Funder types: Other

Identifiers

NCT02235142

2013/01

2012-A01742-41 (Other Identifier)

Details and patient eligibility

About

Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.

Enrollment: 1,614 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,...) or hormonal therapy, showing indication of radical prostatectomy.

Exclusion criteria

• Absence of radical prostatectomy indication
• Patient received local or hormonal therapy prior to surgery
• Patients already enrolled in other clinical study incompatible with the study
• Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)

Trial design

Primary purpose: Other

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

1,614 participants in 1 patient group

Localised prostat cancer and androgen deficiency

Experimental group

Treatment:

Other: Blood sample